Park Place Capital Corp Spring Works Therapeutics, Inc. Transaction History
Park Place Capital Corp
- $323 Million
- Q1 2025
A detailed history of Park Place Capital Corp transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Park Place Capital Corp holds 37 shares of SWTX stock, worth $1,719. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37Holding current value
$1,719% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding SWTX
# of Institutions
361Shares Held
63.1MCall Options Held
5.81MPut Options Held
2.55M-
Vanguard Group Inc Valley Forge, PA7.08MShares$329 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$261 Million0.0% of portfolio
-
State Street Corp Boston, MA2.92MShares$135 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.58MShares$120 Million0.01% of portfolio
-
Woodline Partners LP San Francisco, CA2.14MShares$99.6 Million0.66% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.9B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...